Market Overview

NantHealth Q4 Earnings Preview


Don't be caught off-guard: NantHealth (NASDAQ: NH) releases its next round of earnings Wednesday.

Want to skip the homework and get all the facts in one place? We thought so. Here is your everything-that-matters guide for Wednesday's Q4 earnings announcement after the bell.

Earnings and Revenue

Sell-side analysts are expecting NantHealth's loss per share to be near 14 cents on sales of $23.28 million.

NantHealth reported a per-share loss of 18 cents when it published results during the same quarter last year. Sales in that period totaled $24 million. Sales would be down 3.33 percent from the same quarter last year.

Here's how the company's reported EPS has stacked up against analyst estimates in the past:


Quarter Q3 2017 Q2 2017 Q1 2017 Q4 2016
EPS Estimate -0.13 -0.15   -0.17
EPS Actual -0.13 -0.18 -0.24 -0.18


Stock Performance

Over the past 52-week period, shares of NantHealth have declined 11.46 percent. Given that these returns are generally negative, long-term shareholders are probably a little upset going into this earnings release. Long-term shareholders are already enjoying 12-month gains prior to the announcement.

Analysts have adjusted their estimates higher for EPS and revenues over the past 90 days. The average rating by analysts on NantHealth stock is a Buy. The strength of this rating has risen over the past 90 days.

Conference Call

The NantHealth's Q4 conference call is scheduled to begin at 4:30 p.m. ET.

Posted-In: Earnings News Previews Trading Ideas


Related Articles (NH)

View Comments and Join the Discussion!
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at

Benzinga's Top Upgrades, Downgrades For March 14, 2018

Channel Checks Suggest A Solid Q1 For Adobe: Morgan Stanley Previews The Print